Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;10(4):601-606.
doi: 10.1111/1759-7714.12954. Epub 2019 Feb 26.

HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers

Feng Hua  1 , Yonglu Guo  2 , Qiang Sun  3 , Leizhou Yang  4 , Fang Gao  1
Affiliations

HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers

Feng Hua et al. Thorac Cancer. 2019 Apr.

Abstract

Background: The aim of this study was to evaluate the association between CYP2A13 polymorphisms and lung cancer susceptibility using the HapMap database.

Methods: A case-control analysis of 532 subjects with lung cancer and 614 controls with no personal history of the disease was performed. The tag SNPs rs1645690 and rs8192789 for CYP2A13 were selected, and the genetic polymorphisms were confirmed experimentally through real-time PCR, cloning, and sequencing assay.

Results: SNP frequency in this study was consistent with the HapMap Project database of Han-Chinese and lung cancer risk was associated with CYP2A13 polymorphisms in non-smokers. CYP2A13 shares a 93.5% identity with CYP2A6 in the amino acid sequence and the homologous sequences may interfere with the study of SNPs of CYP2A13.

Conclusions: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers. The common polymorphisms of CYP2A13 may be candidate biomarkers for lung cancer susceptibility in Han-Chinese.

Keywords: CYP2A13; HapMap Project; genetic polymorphism; lung cancer; susceptibility.

PubMed Disclaimer

References

    1. Hua F, Zhou Q. [Research progress of lung cancer on single nucleotide polymorphism]. Zhongguo Fei Ai Za Zhi 2011; 14: 156–64. (In Chinese.). - PMC - PubMed
    1. Leclerc J, Courcot‐Ngoubo NE, Cauffiez C et al. Xenobiotic metabolism and disposition in human lung: Transcript profiling in non‐tumoral and tumoral tissues. Biochimie 2011; 93: 1012–27. - PubMed
    1. Chiang HC, Wang CK, Tsou TC. Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. Respiration 2012; 84: 319–26. - PubMed
    1. Fukami T, Nakajima M, Matsumoto I, Zen Y, Oda M, Yokoi T. Immunohistochemical analysis of CYP2A13 in various types of human lung cancers. Cancer Sci 2010; 101: 1024–8. - PMC - PubMed
    1. Chiang HC, Lee H, Chao HR, Chiou YH, Tsou TC. Pulmonary CYP2A13 levels are associated with early occurrence of lung cancer‐its implication in mutagenesis of non‐small cell lung carcinoma. Cancer Epidemiol 2013; 37: 653–9. - PubMed

Publication types

LinkOut - more resources